The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179: 1634-1647.
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, S.
Right arrow Articles by Lipsky, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, S.
Right arrow Articles by Lipsky, P. E.

Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation

Sheng Chen*,{dagger}, Gary P. Sims1,*, Xiao Xiang Chen{dagger}, Yue Ying Gu{dagger}, Shunle Chen{dagger} and Peter E. Lipsky2,*

* Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892; and {dagger} Shanghai Clinical Center for Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) can modulate immune responses, but whether it directly affects B cell function is unknown. Patients with systemic lupus erythematosus, especially those with antinuclear Abs and increased disease activity, had decreased 1,25(OH)2D3 levels, suggesting that vitamin D might play a role in regulating autoantibody production. To address this, we examined the effects of 1,25(OH)2D3 on B cell responses and found that it inhibited the ongoing proliferation of activated B cells and induced their apoptosis, whereas initial cell division was unimpeded. The generation of plasma cells and postswitch memory B cells was significantly inhibited by 1,25(OH)2D3, although the up-regulation of genetic programs involved in B cell differentiation was only modestly affected. B cells expressed mRNAs for proteins involved in vitamin D activity, including 1{alpha}-hydroxylase, 24-hydroxylase, and the vitamin D receptor, each of which was regulated by 1,25(OH)2D3 and/or activation. Importantly, 1,25(OH)2D3 up-regulated the expression of p27, but not of p18 and p21, which may be important in regulating the proliferation of activated B cells and their subsequent differentiation. These results indicate that 1,25(OH)2D3 may play an important role in the maintenance of B cell homeostasis and that the correction of vitamin D deficiency may be useful in the treatment of B cell-mediated autoimmune disorders.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Current address: Medimmune, One Medimmune Way, Gaithersburg, MD 20878.

2 Address correspondence and reprint requests to Dr. Peter E. Lipsky, Intramural Research Program Autoimmunity Branch Chief, National Institute of Arthritis and Musculoskeletal and Skin Diseases, 9000 Rockville Pike, Building 10, Room 6D47C, Bethesda, MD 20892. E-mail address: lipskyp{at}mail.nih.gov

3 Abbreviations used in this paper: 1,25(OH)2D3, 1,25-dihydroxyvitamin D3; AID, activation-induced cytidine deaminase; ANA, antinuclear Ab; beta2M, beta2-microglobulin; BCL6, B cell lymphoma 6; BLIMP1, B lymphocyte-induced maturation protein 1; DC, dendritic cell; ERN1, endoplasmic reticulum to nucleus signaling; IRF4, IFN regulatory factor 4; PI, propidium iodide; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SLEDAI, SLE disease activity index; VDR, vitamin D3 receptor; XBP1, X box-binding protein.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Endocr. Rev., October 1, 2008; 29(6): 726 - 776.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Liu, L. Nguyen, R. F. Chun, V. Lagishetty, S. Ren, S. Wu, B. Hollis, H. F. DeLuca, J. S. Adams, and M. Hewison
Altered Endocrine and Autocrine Metabolism of Vitamin D in a Mouse Model of Gastrointestinal Inflammation
Endocrinology, October 1, 2008; 149(10): 4799 - 4808.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Borgogni, E. Sarchielli, M. Sottili, V. Santarlasci, L. Cosmi, S. Gelmini, A. Lombardi, G. Cantini, G. Perigli, M. Luconi, et al.
Elocalcitol Inhibits Inflammatory Responses in Human Thyroid Cells and T Cells
Endocrinology, July 1, 2008; 149(7): 3626 - 3634.
[Abstract] [Full Text] [PDF]


Home page
Poult. Sci.Home page
D. Praslickova, S. Sharif, A. Sarson, M. F. Abdul-Careem, D. Zadworny, A. Kulenkamp, G. Ansah, and U. Kuhnlein
Association of a Marker in the Vitamin D Receptor Gene with Marek's Disease Resistance in Poultry
Poult. Sci., June 1, 2008; 87(6): 1112 - 1119.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A.-K. Shirakawa, D. Nagakubo, K. Hieshima, T. Nakayama, Z. Jin, and O. Yoshie
1,25-Dihydroxyvitamin D3 Induces CCR10 Expression in Terminally Differentiating Human B Cells
J. Immunol., March 1, 2008; 180(5): 2786 - 2795.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.